From a global, biological perspective this in-fighting over alleged medical and religious ethics is in fact nothing less than an all out affront to environmental sustainability.

FORBES: Planet Under Siege: Family Planning Critics Soon To See Global Population Reach 7,000,000,000

The bottom line is that for the time being, from a regulatory perspective each biosimilar version of an approved biological product will be regarded as, in effect, a completely new and distinct drug.

FORBES: Do You Think 'Biosimilars' Will Reduce Healthcare Expenditures? Think again.